GSK-backed Liquidia takes a seat at the IPO table, looking for a $57.5M stake to take on United Therapeutics
Liquidia Technologies believes the time is ripe to go public, asking investors to sign on for a $57.5 million IPO designed to get them …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
